舒肝健脾活血方对脾切断流术后门静脉血栓形成相关因子的
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R543.6;R657.3+4

基金项目:

河南省中医药科学研究专项课题项目(2017ZY2054)


Effect of Shugan Jianpi Huoxue Prescription on Related Factors of Portal Vein Thrombosis After Splenectomy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察舒肝健脾活血方对脾切断流术后门静脉血栓形成(PVT) 相关因子的影响。方法:选取门静脉高压症行脾切断流术患者105 例,随机分为研究组53 例与对照组52 例。2 组均从术后第3 天起应用阿司匹林治疗,研究组于术前3 天开始给予舒肝健脾活血方。2 组疗程均为术后14 d。观察比较围手术期不同时间点(术前、术后3、7、14 d) P-选择素、基质金属蛋白酶-9 (MMP-9) 水平及抗凝血酶Ⅲ (AT-Ⅲ) 活性。结果:术后3、7 d,2 组P-选择素水平均较前一时间点升高(P<0.05),术后14 d,2 组P-选择素水平较术后7 d 降低(P<0.05);且术后7、14 d 时,研究组P-选择素水平明显低于对照组(P<0.05)。术后3、7 d,2 组MMP-9 水平均较前一时间点升高(P<0.05),术后14 d,2 组MMP-9 水平较术后7 d 降低(P<0.05);且术后7、14 d,研究组MMP-9 水平明显低于对照组(P<0.05)。术后3、7、14 d,2 组AT-Ⅲ水平均较术前降低(P<0.05),而研究组术后各时间点AT-Ⅲ水平均明显高于对照组(P<0.05)。结论:舒肝健脾活血方对脾切断流术后PVT 形成相关因子P-选择素、MMP-9 水平具有一定的抑制作用,同时可促进AT-Ⅲ活性的恢复。

    Abstract:

    Abstract: Objective: To observe the effect of Shugan Jianpi Huoxue prescription on related factors of portal vein thrombosis(PVT) after splenectomy. Methods: A total of 105 cases of patients who had portal hypertension and received splenectomy were selected and randomly divided into the study group and the control group,with 53 and 52 cases in each group respectively. Both groups were treated with aspirin since the 3rd day after the surgery,and the study group was given the oral administration of Shugan Jianpi Huoxue prescription from the 3rd day before the surgery. The course of treatement of the two groups was 14 days after the surgery. The levels of P- selectin and matrix metalloproteinase- 9(MMP- 9) and the activity of antithrombin Ⅲ(AT-Ⅲ) at different time points during perioperative period(before the surgery,on the 3rd,the 7th and the 14th day after the surgery) were observed and compared. Results:On the 3rd and the 7th day after the surgery,Pselectin levels in the two groups were increased when compared with those at the previous time point(P<0.05);on the 14th day after the surgery,the levels in the two groups were decreased when compared with those on the 7th day after the surgery (P<0.05);on the 7th and the 14th day after the surgery,the level in the study group was significantly lower than that in the control group(P<0.05). On the 3rd and the 7th day after the surgery,MMP-9 levels in the two groups were increased when compared with those at the previous time point(P<0.05);on the 14th day after the surgery,the MMP- 9 levels in the two groups were decreased when compared with those on the 7th day after the surgery(P<0.05);on the 7th and the 14th day after the surgery,the level in the study group was significantly lower than that in the control group(P<0.05). On the 3rd,the 7th and the 14th day after the surgery, the level of AT- Ⅲ in the two groups was decreased when compared with that before the surgery(P<0.05);and the level of AT-Ⅲ in the study group was significantly higher than that in the control group at each time point after operation(P<0.05). Conclusion:Shugan Jianpi Huoxue prescription has a certain inhibitory effect on the levels of P-selectin and MMP-9 which are related factors of portal vein thrombosis after splenectomy,and is helpful to the recovery of AT-III activity.

    参考文献
    相似文献
    引证文献
引用本文

王兆阳,苑军正,张楠.舒肝健脾活血方对脾切断流术后门静脉血栓形成相关因子的[J].新中医,2022,54(2):71-74

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-22
  • 出版日期: